Zusammenfassung
Die Ergebnisse der Hypertension Optimal Treatment (HOT)-Studie (Tabelle 26.2) haben belegt, dass die Häufigkeit kardiovaskulärer Ereignisse proportional zur Senkung des arteriellen Blutdruckes abnimmt. Der Nutzen einer möglichst effektiven Blutdrucksenkung ist für Hypertoniker mit gleichzeitig bestehendem Diabetes mellitus noch größer als für nichtdiabetische Patienten. Während bei Hypertonikern ohne zusätzliche Risikofaktoren der Blutdruck mindestens auf Werte <140/90 mmHg zu senken ist, sollten Hochrisikopatienten mit diabetischer Nephropathie oder Hypertoniker mit begleitender koronarer Herzkrankheit Blutdruckwerte von <130/80 mmHg anstreben.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bakris GL, Griffin KA, Picken MM, Bidani AK (1997) Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury. J Hypertension 15:1181–1185
Bakris GL, Weir MR, De Quattro V, McMahon FG (1998) Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 54:1283–1289
Brown MJ, Dickerson JEC (1995) Alpha-blockade and calcium antagonism: an effective and well-tolerated combination for the treatment of resistant hypertension. J Hypertension 13:701–707
Chalmers J (1999) The importance of drug combinations for effective control of hypertension. Clin Exper Hypertension 21:875–884
Chalmers J, Castaigne A, Morgan T, Chastang C (2000) Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients. Hypertension 18:327–337
Fenichel RR, Lipicky RJ (1994) Combination products as first-line pharmacotherapy. Arch Intern Med 154:1461–1468
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Menard J, Julius S, Rahn KH, Wedel H, Westerling S for the HOT Study Group (1998) Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension. Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755–1762
Hilleman DE, Ryschon KL, Mohiuddin SM, Wurdeman RL (1999) Fixed-dose combination vs. monotherapy in hypertension: a meta-analysis evaluation. J Hum Hypertension 13:477–483
Holzgreve H (1996) Antihypertensive Therapie mit fixen Kombinationen. Internist 37:852–856
Kaplan NM (1999) Low dose combinations in the treatment of hypertension: theory and practice. J Hum Hypertension 13:707–710
Kendall MJ (1995) Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metropolol. Drugs 50:454–464
Menard J, Bellet M (1993) Calcium antagonists-ACE inhibitors combination therapy: objectives and methodology of clinical development. J Cardiovasc Pharmacol 21(suppl 2):S49–S54
Messerli FH (1999) Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists. Am J Hypertension 12:86S–90S
Neutel JM (1999) Low-dose antihypertensive combination therapy: Its rationale and role in cardiovascular risk management. Am J Hypertension 12:73S–79S
Ruilope LM (1999) Is it wise to combine an ACE inhibitor and an angiotensin receptor antagonist? Nephrol Dial Transplant 14:2855–2856
Waeber B, Brunner HR (1995) Main objectives and new aspects of combination treatment of hypertension. J Hypertens 13(suppl 2):S15–S19
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Stimpel, M. (2001). Antihypertensive Kombinationstherapie. In: Arterielle Hypertonie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57617-1_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-57617-1_30
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-63309-6
Online ISBN: 978-3-642-57617-1
eBook Packages: Springer Book Archive